| |
| Program description: The
McLendon Clinical Laboratories of UNC Hospitals
offer a one-year fellowship in molecular genetic pathology. The fellow
gains
a
working
knowledge
of molecular procedures including DNA and RNA extraction, Southern
blot, in situ hybridization/FISH, sequencing, and amplification methods.
Trainees are exposed to tissue microdissection and array technologies.
These technologies are applied in a wide spectrum of clinical settings
including cancer, inherited disease, infectious disease, HLA-typing,
and identification. The fellow learns to analyze and interpret molecular
data from clinical cases, and to compose diagnostic reports. Results
are correlated with clinical, morphologic, immunophenotypic, and cytogenetic
findings. The fellow learns to design and carry out research projects
aimed at understanding the molecular basis of disease or translating
such basic discoveries into improved patient care. Fellows may apply
for an optional second year of full time research. Ethical issues,
quality assurance, and lab administration are discussed as they relate
to clinical practice and research in molecular pathology. UNC Hospitals
is among the first molecular fellowship programs in the country to
be accredited by the ACGME, thus allowing our trainees to apply for
subspecialty certification in molecular genetic pathology. |
| |
| Program requirements: Candidates
must have an MD degree. AP/CP board eligibility/certification is preferred. |
| |
| Stipends: Fellowship
stipends are based on the trainee's number of years of postdoctoral
training and the current UNC Hospitals' Housestaff
salary scale. |
| |
| Program director: Margaret
L. Gulley, MD, Director of Molecular Genetics Laboratory |
| |
Applications: Applications
should be submitted no later than October 1 prior to the intended fellowship
start date of July 1. UNC Hospitals' Housestaff
Contract and Policies are available online for review.
To apply, please send a cover letter, curriculum vitae, and the
names of three references to the Program Director at the address
below. |
| |
| For additional information, please contact |
Margaret L. Gulley MD
Department of Pathology and Laboratory Medicine
CB# 7525
Chapel Hill, NC 27599-7525
|
|
|
E-mail: margaret_gulley@med.unc.edu
Telephone: 919-843-4595 |
|
|
|
| |
|
| |
| |
The goal of the MGP fellowship is to
produce physicians with special expertise in molecular pathology
who are competent clinical consultants on issues related to the application
of DNA/RNA technology in a wide variety of clinical settings. The
trainees are made ready to direct clinical or research laboratories
by applying the knowledge and skills that they have acquired in molecular
diagnostics, in research, and in laboratory administration. Their
fundamental understanding of genomics and of hybridization technologies
prepares them to continue to read the literature, understand new
molecular methods that are introduced in future years, apply those
methods to solve practical clinical problems, and become lifelong
learners.
Training in Molecular Genetic Pathology is provided through
didactic seminars; hands-on experience with laboratory techniques;
preparation of clinical cases for sign out under the supervision
of qualified faculty; interaction with clinicians, counselors,
and laboratory scientists; and research projects.
Specific Objectives of the Molecular Genetic Pathology Fellowship
are: |
| |
| 1. Gain a working knowledge of molecular
genetic procedures including DNA and RNA extraction, Southern blot,
in situ hybridization/FISH, sequencing, and amplification methods
(PCR, rtPCR, real-time PCR, NASBA, LCR, SDA, and bDNA). |
| 2. Learn diagnostic applications of
molecular technologies in a wide spectrum of clinical settings
including
cancer, inherited disease, infectious disease, HLA-typing, and
identification. |
| 3. Learn to analyze and interpret molecular
data from clinical cases, and compose diagnostic reports. |
| 4. Correlate results of genetic testing
with clinical, morphologic, immunophenotypic, cytogenetic findings,
and other clinicopathologic information. |
| 5. Learn how to design and carry out
research projects aimed at understanding the molecular basis of
disease. |
| 6. Perform translational research aimed
at applying basic research findings and molecular technologies
towards a goal of improving patient care. |
| 7. Discuss issues of ethics, quality
assurance, and lab administration as they relate to clinical practice
and research in molecular pathology. |
| |
|
| |
| |
| Displayed below is a block diagram of a typical fellow's rotations
and assignments. Fellows learn the fundamentals of molecular pathology
during mandatory rotations in the three clinical laboratories where
molecular methods are commonly applied, namely the Molecular Genetics
Laboratory, the Cytogenetics/FISH laboratory, and the Microbiology/
Virology/ HLA laboratory. These clinical lab rotations, along with
a month-long structured course in molecular diagnostics, comprise the
first half of the fellowship year. Research is performed throughout
the year, and the research experience is further enhanced by at least
3 months of protected time for studies in the latter half of the year.
An optional second year of full time research is available to qualified
fellows. |
| |
| |
July/Aug |
September |
October |
Nov/Dec |
Jan-Mar |
Apr-June |
| First year in program |
Molecular Lab (inherited disease, cancer, identity) |
Molecular Diagnostics/
Cytogenetics Course |
Cytogenetics & FISH Lab (congenital disease, cancer) |
Microbiology/
Virology/
HLA Lab
(infectious disease, HLA) |
Clinical Electives with case accrual |
Mentored Research Electives |
| Second year in program
(optional) |
Experimental Pathology Fellowship (Mentored Research) |
|
| |
| |
| |
Following 6 months of structured training,
the schedule becomes more flexible in order to accommodate the fellow’s
previous training, experience, and career goals. Clinical elective
rotations may be chosen in any of the three core molecular laboratories
or in services where molecular assays are applied to only a small
proportion of cases, such as autopsy, forensics, toxicology, cytopathology,
surgical
pathology, neuropathology, dermatopathology, hematology, coagulation,
blood bank/transfusion medicine, immunopathology, chemistry, biochemical
laboratory, newborn screening lab, prenatal triple testing lab, prenatal
clinic, and medical genetics clinic. These rotations build upon existing
clinical rotations for our AP/CP and genetics residents and subspecialty
fellows, with the caveat that the MGP fellow is expected to emphasize
the role of molecular diagnostics in medical practice and in understanding
disease pathogenesis in the area. This emphasis is demonstrated through
active case acquisitions and through conference presentations.
To demonstrate their clinical experience, the fellow must maintain
a logbook of molecular cases in which they were substantially involved.
A case is defined as the complete evaluation of a patient or a specimen,
including oversight of laboratory testing, interpretation of results,
preparation of report for signout, and clinical consultation. Also
included is direct participation in clinic/inpatient visits with
laboratory consultation regarding indications for testing or transmission
of lab results. A minimum of 150 cases must be acquired to meet the
requirement for MGP board certification. These cases should reflect
a breadth of experience with regard to molecular technologies (PCR,
rtPCR, LCR, Southern blot, PTT, sequencing), and disease types (inherited,
cancer, infectious, HLA, and identity). |
| |
| |
| |
| Research experience is mandatory for MGP fellows, and the goal of
this experience is to make our fellows ready to become creative leaders
of future basic and applied research efforts. To this end, our program
promotes acquisition of a foundation of knowledge, accumulation of
laboratory skills, and formulation of experimental approaches to problem
solving in a modern molecular laboratory setting. Research electives
provide the fellow with a solid block of time in which to complete
their studies. The topic of research should be chosen, under guidance
of the Program Director and pertinent faculty, early in the year and
at least one month prior to the start of any research elective rotation.
Study is conducted under the guidance of the preceptor who is published
and nationally recognized in the chosen area of research. Progress
is monitored by monthly 2-way evaluations along with monthly meetings
with the Program Director. A second year of full-time research is available
to those trainees who successfully compete for departmental or external
funding. In this regard, the Department of Pathology offers a mentored
year-long Experimental Pathology Fellowship which pays the full stipend
for the trainee and provides a bench research fund. Presentation of
research findings at local and national meetings is strongly encouraged. |
| |
| For more information on molecular
pathology at UNC, check out Dr. Gulley's Molecular
Diagnostics Web Page. |
| |
| |
|